Ironwood Pharmaceuticals Inc
NASDAQ:IRWD

Watchlist Manager
Ironwood Pharmaceuticals Inc Logo
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Watchlist
Price: 3.47 USD -0.29%
Market Cap: 564.5m USD

Wall Street
Price Targets

IRWD Price Targets Summary
Ironwood Pharmaceuticals Inc

Wall Street analysts forecast IRWD stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRWD is 2.55 USD with a low forecast of 0.71 USD and a high forecast of 3.99 USD.

Lowest
Price Target
0.71 USD
80% Downside
Average
Price Target
2.55 USD
27% Downside
Highest
Price Target
3.99 USD
15% Upside
Ironwood Pharmaceuticals Inc Competitors:
Price Targets
ADOC
Adocia SA
117% Upside
145020
Hugel Inc
72% Upside
URGN
Urogen Pharma Ltd
54% Upside
VCYT
Veracyte Inc
11% Upside
4974
Takara Bio Inc
45% Upside
BIOPOR
Bioporto A/S
272% Upside
688331
RemeGen Co Ltd
10% Upside
GLPG
Galapagos NV
8% Upside

Revenue
Forecast

Revenue Estimate
Ironwood Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Ironwood Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is -1%.

14%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ironwood Pharmaceuticals Inc

The compound annual growth rate of Ironwood Pharmaceuticals Inc's operating income for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Ironwood Pharmaceuticals Inc

The compound annual growth rate of Ironwood Pharmaceuticals Inc's net income for the next 3 years is 394%.

N/A
Past Growth
394%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IRWD's stock price target?
Price Target
2.55 USD

According to Wall Street analysts, the average 1-year price target for IRWD is 2.55 USD with a low forecast of 0.71 USD and a high forecast of 3.99 USD.

What is Ironwood Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Ironwood Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 3 years is -1%.

What is Ironwood Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
20%

The compound annual growth rate of Ironwood Pharmaceuticals Inc's operating income for the next 3 years is 20%.

What is Ironwood Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
394%

The compound annual growth rate of Ironwood Pharmaceuticals Inc's net income for the next 3 years is 394%.

Back to Top